Quick Answer
Actinium Pharmaceuticals, Inc. reported Total Assets of $51.78 million for the year ending 2025.
- Actinium Pharmaceuticals, Inc. showed a decrease of -32.7% in Total Assets from 2024 to 2025.
- This data is from Actinium Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $150.00 | Q3 2011: $150.00 | Q1 2012: $150.00 | Q3 2012: $0.00 | Q1 2013: $3.36 million | Q2 2013: $5.73 million | Q3 2013: $4.05 million | Q1 2014: $6.56 million | Q2 2014: $15.45 million | Q3 2014: $12.60 million | Q1 2015: $20.06 million | Q2 2015: $26.33 million | Q3 2015: $25.05 million | Q1 2016: $23.34 million | Q2 2016: $21.57 million | Q3 2016: $17.26 million | Q1 2017: $18.24 million | Q2 2017: $12.98 million | Q3 2017: $21.72 million | Q1 2018: $28.14 million | Q2 2018: $22.58 million | Q3 2018: $15.70 million | Q1 2019: $12.24 million | Q2 2019: $21.82 million | Q3 2019: $16.32 million | Q1 2020: $8.36 million | Q2 2020: $55.96 million | Q3 2020: $50.53 million | Q1 2021: $75.10 million | Q2 2021: $84.45 million | Q3 2021: $84.48 million | Q1 2022: $74.56 million | Q2 2022: $121.80 million | Q3 2022: $116.82 million | Q1 2023: $102.03 million | Q2 2023: $99.05 million | Q3 2023: $88.94 million | Q1 2024: $88.35 million | Q2 2024: $89.86 million | Q3 2024: $82.11 million | Q1 2025: $68.65 million | Q2 2025: $63.02 million | Q3 2025: $56.15 million.
- Over the full 16 years of available data (2010 to 2025), Actinium Pharmaceuticals, Inc.'s Total Assets has grown by 34,516,566.7%.
- Historical annual values: Fiscal year 2025: $51.78 million | Fiscal year 2024: $76.90 million | Fiscal year 2023: $81.45 million | Fiscal year 2022: $114.19 million | Fiscal year 2021: $80.39 million | Fiscal year 2020: $66.40 million | Fiscal year 2019: $11.67 million | Fiscal year 2018: $14.89 million | Fiscal year 2017: $18.34 million | Fiscal year 2016: $22.53 million | Fiscal year 2015: $26.59 million | Fiscal year 2014: $7.57 million | Fiscal year 2013: $5.77 million | Fiscal year 2012: $5.79 million | Fiscal year 2011: $6.20 million | Fiscal year 2010: $150.00.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: